SSX5
gene geneOn this page
Summary
SSX5 (SSX family member 5, HGNC:11339) is a protein-coding gene on chromosome Xp11.23, encoding Protein SSX5 (O60225). Could act as a modulator of transcription.
The product of this gene belongs to the family of highly homologous synovial sarcoma X (SSX) breakpoint proteins. These proteins may function as transcriptional repressors. They are also capable of eliciting spontaneous humoral and cellular immune responses in cancer patients, and are potentially useful targets in cancer vaccine-based immunotherapy. While some of the related SSX genes are involved in t(X;18)(p11.2;q11.2) translocations that are characteristically found in all synovial sarcomas, this gene does not appear to be involved in such translocations. Two transcript variants encoding distinct isoforms have been identified for this gene.
Source: NCBI Gene 6758 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 61 total
- MANE Select transcript:
NM_175723
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:11339 |
| Approved symbol | SSX5 |
| Name | SSX family member 5 |
| Location | Xp11.23 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000165583 |
| Ensembl biotype | protein_coding |
| OMIM | 300327 |
| Entrez | 6758 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 2 protein_coding, 1 retained_intron
ENST00000311798, ENST00000347757, ENST00000403001
RefSeq mRNA: 2 — MANE Select: NM_175723
NM_021015, NM_175723
CCDS: CCDS14288, CCDS14289
Canonical transcript exons
ENST00000347757 — 8 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001185445 | 48186220 | 48186856 |
| ENSE00001606345 | 48187627 | 48187731 |
| ENSE00001621496 | 48190133 | 48190268 |
| ENSE00001673963 | 48194129 | 48194224 |
| ENSE00001696914 | 48192232 | 48192281 |
| ENSE00001729090 | 48194740 | 48194854 |
| ENSE00001741936 | 48195290 | 48195378 |
| ENSE00003915234 | 48196731 | 48196795 |
Expression profiles
Bgee: expression breadth broad, 36 present calls, max score 87.50.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0099 / max 11.7504, expressed in 2 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 199150 | 0.0099 | 2 |
Top tissues by expression
233 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 87.50 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 78.04 | silver quality |
| triceps brachii | UBERON:0001509 | 75.20 | gold quality |
| gluteal muscle | UBERON:0002000 | 75.17 | gold quality |
| vastus lateralis | UBERON:0001379 | 68.21 | gold quality |
| quadriceps femoris | UBERON:0001377 | 67.45 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 67.19 | gold quality |
| diaphragm | UBERON:0001103 | 65.90 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 65.31 | gold quality |
| biceps brachii | UBERON:0001507 | 64.77 | gold quality |
| tongue squamous epithelium | UBERON:0006919 | 64.06 | gold quality |
| cerebellar vermis | UBERON:0004720 | 63.43 | gold quality |
| Brodmann (1909) area 10 | UBERON:0013541 | 63.41 | gold quality |
| frontal pole | UBERON:0002795 | 62.85 | gold quality |
| buccal mucosa cell | CL:0002336 | 62.81 | gold quality |
| cervix squamous epithelium | UBERON:0006922 | 61.93 | gold quality |
| middle frontal gyrus | UBERON:0002702 | 60.80 | gold quality |
| paraflocculus | UBERON:0005351 | 60.36 | gold quality |
| vena cava | UBERON:0004087 | 60.08 | gold quality |
| deltoid | UBERON:0001476 | 58.59 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 58.54 | gold quality |
| subthalamic nucleus | UBERON:0001906 | 57.43 | gold quality |
| heart right ventricle | UBERON:0002080 | 57.40 | gold quality |
| metanephric glomerulus | UBERON:0004736 | 57.38 | gold quality |
| secondary oocyte | CL:0000655 | 57.29 | gold quality |
| nephron tubule | UBERON:0001231 | 57.24 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 57.17 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 57.12 | gold quality |
| oral cavity | UBERON:0000167 | 56.92 | gold quality |
| dorsal plus ventral thalamus | UBERON:0001897 | 56.64 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 2.79 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
32 targeting SSX5, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6867-5P | 100.00 | 82.21 | 3464 |
| HSA-MIR-34A-5P | 99.99 | 71.21 | 1784 |
| HSA-MIR-449A | 99.99 | 71.05 | 1776 |
| HSA-MIR-4500 | 99.99 | 72.72 | 2367 |
| HSA-MIR-34C-5P | 99.97 | 70.45 | 1577 |
| HSA-MIR-449B-5P | 99.97 | 70.26 | 1580 |
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
| HSA-MIR-7162-3P | 99.89 | 68.16 | 1682 |
| HSA-MIR-12119 | 99.87 | 68.35 | 1653 |
| HSA-MIR-5003-3P | 99.85 | 69.29 | 2517 |
| HSA-MIR-4255 | 99.72 | 67.70 | 1541 |
| HSA-MIR-518A-5P | 99.70 | 69.01 | 2209 |
| HSA-MIR-527 | 99.70 | 69.01 | 2209 |
| HSA-MIR-1208 | 99.70 | 68.28 | 1533 |
| HSA-MIR-586 | 99.65 | 70.40 | 2051 |
| HSA-MIR-4276 | 99.56 | 67.66 | 2514 |
| HSA-MIR-8064 | 99.45 | 66.92 | 875 |
| HSA-MIR-3678-3P | 99.31 | 67.10 | 1432 |
| HSA-MIR-4641 | 99.28 | 66.64 | 744 |
| HSA-MIR-6868-5P | 99.06 | 65.69 | 1284 |
| HSA-MIR-2467-3P | 98.65 | 67.18 | 1969 |
| HSA-MIR-10226 | 98.25 | 66.50 | 811 |
| HSA-MIR-3650 | 97.88 | 64.89 | 693 |
| HSA-MIR-204-3P | 97.80 | 66.84 | 1656 |
| HSA-MIR-4646-5P | 97.70 | 66.84 | 1692 |
| HSA-MIR-4253 | 97.48 | 65.11 | 692 |
| HSA-MIR-6862-5P | 97.48 | 64.84 | 713 |
| HSA-MIR-134-5P | 97.11 | 66.52 | 976 |
| HSA-MIR-3118 | 97.11 | 66.58 | 984 |
| HSA-MIR-549A-5P | 96.35 | 68.08 | 587 |
Literature-anchored findings (GeneRIF, showing 1)
- Two kinds of cancer-testis antigen, SSX-2 and SSX-5 showed high-specific and high-frequent expression in hepatocellular carcinoma tissues, but neither of them could be detected in adjacent non-HCC tissues. (PMID:16546222)
Cross-species orthologs
15 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Ssxb2 | ENSMUSG00000023165 |
| mus_musculus | Ssxb13 | ENSMUSG00000035371 |
| mus_musculus | Ssxa1 | ENSMUSG00000062814 |
| mus_musculus | Ssxb9 | ENSMUSG00000068218 |
| mus_musculus | Ssxb10 | ENSMUSG00000068219 |
| mus_musculus | Ssxb5 | ENSMUSG00000071816 |
| mus_musculus | Ssxb16 | ENSMUSG00000079697 |
| mus_musculus | Ssxb14 | ENSMUSG00000079699 |
| mus_musculus | Ssxb3 | ENSMUSG00000079701 |
| mus_musculus | Ssxb6 | ENSMUSG00000079702 |
| mus_musculus | Ssxb8 | ENSMUSG00000079703 |
| mus_musculus | Ssxb15 | ENSMUSG00000079704 |
| mus_musculus | Ssxb1 | ENSMUSG00000079705 |
| rattus_norvegicus | Ssx1 | ENSRNOG00000027850 |
| rattus_norvegicus | Ssx2 | ENSRNOG00000049427 |
Paralogs (7): SSX1 (ENSG00000126752), SSX3 (ENSG00000165584), SSX7 (ENSG00000187754), SSX2 (ENSG00000241476), SSX4 (ENSG00000268009), SSX2B (ENSG00000268447), SSX4B (ENSG00000269791)
Protein
Protein identifiers
Protein SSX5 — O60225 (reviewed: O60225)
All UniProt accessions (1): O60225
UniProt curated annotations — full annotation on UniProt →
Function. Could act as a modulator of transcription.
Similarity. Belongs to the SSX family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| O60225-1 | 1 | yes |
| O60225-2 | 2 |
RefSeq proteins (2): NP_066295, NP_783729* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR003655 | aKRAB | Domain |
| IPR019041 | SSXRD_motif | Conserved_site |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
Pfam: PF09514
UniProt features (10 total): compositionally biased region 4, chain 1, domain 1, region of interest 1, splice variant 1, sequence variant 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-O60225-F1 | 67.20 | 0.27 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 42 (showing top):
BROWNE_HCMV_INFECTION_30MIN_DN, MODULE_59, TGCTGAY_UNKNOWN, OCT1_06, ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN, MORF_IL9, EVI1_04, PARENT_MTOR_SIGNALING_UP, chrXp11, MIR6867_5P, MIR34A_5P, MIR449A, MIR2467_3P, MIR3678_3P, MIR549A_5P
GO Biological Process (1): regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (1): nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
172 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SSX5 | SS18 | Q15532 | 737 |
| SSX5 | ZNF117 | Q03924 | 688 |
| SSX5 | ZNF83 | P51522 | 687 |
| SSX5 | IGSF22 | Q8N9C0 | 511 |
| SSX5 | MAGEB1 | P43366 | 423 |
| SSX5 | MAGEC2 | Q9UBF1 | 399 |
| SSX5 | CTAG1A | P78358 | 398 |
| SSX5 | SSX2IP | Q9Y2D8 | 396 |
| SSX5 | MAGEA1 | P43355 | 392 |
| SSX5 | MAGEA3 | P43357 | 392 |
| SSX5 | CTAG2 | O75638 | 391 |
| SSX5 | MAGEB2 | O15479 | 375 |
| SSX5 | SPANXA1 | Q9NS26 | 373 |
| SSX5 | TTC32 | Q5I0X7 | 366 |
| SSX5 | MAGED4B | Q96JG8 | 360 |
IntAct
9 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SSX5 | AGTRAP | psi-mi:“MI:0915”(physical association) | 0.740 |
| AGTRAP | SSX5 | psi-mi:“MI:0915”(physical association) | 0.740 |
| SSX5 | ZSCAN1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| NFE2 | SSX5 | psi-mi:“MI:0915”(physical association) | 0.370 |
| SSX5 | PCBD2 | psi-mi:“MI:0915”(physical association) | 0.370 |
BioGRID (11): AGTRAP (Two-hybrid), SSX5 (Affinity Capture-MS), SSX5 (Two-hybrid), SSX5 (Two-hybrid), CMTM5 (Two-hybrid), AGTRAP (Two-hybrid), GOLGA6L9 (Two-hybrid), SSX5 (Negative Genetic), SSX5 (Two-hybrid), PCBD2 (Two-hybrid), ZSCAN1 (Two-hybrid)
ESM2 similar proteins: A6H5X4, B1AUS7, D0QMC3, O35368, O60224, O60225, P0C6Y7, P0DOV1, P0DOV2, P23497, P41218, Q15361, Q16384, Q16385, Q16666, Q2KIN0, Q3U827, Q3ZCI6, Q4R7Q1, Q504N7, Q5H9L4, Q5I0E2, Q5I0J8, Q5RAK3, Q5RCZ8, Q5RD14, Q5W0A0, Q62187, Q6K0P9, Q71F23, Q7RTT3, Q7RTT4, Q7RTT5, Q7RTT6, Q86T96, Q8BV49, Q8BVM9, Q8C0V1, Q8C6C7, Q8CGE8
Diamond homologs: B1AUS7, O60224, O60225, P0C6Y7, Q16384, Q16385, Q7RTT3, Q7RTT4, Q7RTT5, Q7RTT6, Q8BFS8, Q96EQ9, Q99909, Q9NQV7, Q9NQW5, Q6ZMS7, A0A163UT06, A2AGX3, B8A5Y1, E9Q3T6, O75626, P10072, P52736, Q13029, Q14929, Q60636, Q63755, Q6P1L6, Q6P2A1, Q86UQ0, Q8BZ97, Q8TD17, Q9GZV8, Q9NQV5, Q9NQV8, Q9ULD5, Q9Y3M9, A2AJ77, C9JBD0, P14404
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
61 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 42 |
| Likely benign | 12 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1091 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| X:48187620:CACT:C | donor_loss | 1.0000 |
| X:48187621:ACTT:A | donor_loss | 1.0000 |
| X:48187622:CTTAC:C | donor_loss | 1.0000 |
| X:48187623:TTACG:T | donor_loss | 1.0000 |
| X:48187624:TA:T | donor_loss | 1.0000 |
| X:48187625:A:AC | donor_gain | 1.0000 |
| X:48187626:C:CT | donor_gain | 1.0000 |
| X:48187626:CG:C | donor_gain | 1.0000 |
| X:48187626:CGG:C | donor_gain | 1.0000 |
| X:48187626:CGGA:C | donor_gain | 1.0000 |
| X:48187644:T:TA | donor_gain | 1.0000 |
| X:48187730:TCC:T | acceptor_loss | 1.0000 |
| X:48187732:C:CC | acceptor_gain | 1.0000 |
| X:48187733:T:G | acceptor_loss | 1.0000 |
| X:48190271:T:C | acceptor_gain | 1.0000 |
| X:48190271:T:TC | acceptor_gain | 1.0000 |
| X:48190273:A:C | acceptor_gain | 1.0000 |
| X:48190276:A:AC | acceptor_gain | 1.0000 |
| X:48190276:A:C | acceptor_gain | 1.0000 |
| X:48190278:G:GC | acceptor_gain | 1.0000 |
| X:48192282:C:CC | acceptor_gain | 1.0000 |
| X:48194121:CTACT:C | donor_loss | 1.0000 |
| X:48194123:ACT:A | donor_loss | 1.0000 |
| X:48194124:CTC:C | donor_loss | 1.0000 |
| X:48194125:TCACC:T | donor_loss | 1.0000 |
| X:48194126:CACC:C | donor_loss | 1.0000 |
| X:48194127:A:AC | donor_gain | 1.0000 |
| X:48194127:A:AG | donor_loss | 1.0000 |
| X:48194127:AC:A | donor_gain | 1.0000 |
| X:48194128:C:CC | donor_gain | 1.0000 |
AlphaMissense
1258 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| X:48194828:G:C | F32L | 0.935 |
| X:48194828:G:T | F32L | 0.935 |
| X:48194830:A:G | F32L | 0.935 |
| X:48194199:G:C | F70L | 0.918 |
| X:48194199:G:T | F70L | 0.918 |
| X:48194201:A:G | F70L | 0.918 |
| X:48194849:G:C | F25L | 0.891 |
| X:48194849:G:T | F25L | 0.891 |
| X:48194851:A:G | F25L | 0.891 |
| X:48194813:C:A | W37C | 0.879 |
| X:48194813:C:G | W37C | 0.879 |
| X:48194768:C:A | K52N | 0.878 |
| X:48194768:C:G | K52N | 0.878 |
| X:48194815:A:G | W37R | 0.789 |
| X:48194815:A:T | W37R | 0.789 |
| X:48194755:C:G | A57P | 0.783 |
| X:48194789:T:A | K45N | 0.780 |
| X:48194789:T:G | K45N | 0.780 |
| X:48194829:A:G | F32S | 0.769 |
| X:48194769:T:G | K52T | 0.738 |
| X:48194804:C:A | M40I | 0.738 |
| X:48194804:C:G | M40I | 0.738 |
| X:48194804:C:T | M40I | 0.738 |
| X:48194805:A:G | M40T | 0.738 |
| X:48194200:A:G | F70S | 0.726 |
| X:48194196:C:A | M71I | 0.723 |
| X:48194196:C:G | M71I | 0.723 |
| X:48194196:C:T | M71I | 0.723 |
| X:48194750:C:A | M58I | 0.722 |
| X:48194750:C:G | M58I | 0.722 |
dbSNP variants (sampled 300 via entrez): RS111262473 (X:48195353 G>A,C,T), RS111366620 (X:48187132 G>C), RS111527014 (X:48190412 A>G), RS111859329 (X:48187139 G>T), RS112204202 (X:48188000 G>A,C), RS112546919 (X:48189983 G>T), RS112687457 (X:48189455 C>T), RS112762672 (X:48187965 G>A), RS112821791 (X:48186400 G>A,C,T), RS1156244500 (X:48194465 G>C), RS1156358441 (X:48195609 G>A,T), RS1156619075 (X:48197551 G>A), RS1156678013 (X:48198482 A>G,T), RS1156964466 (X:48190298 G>GT), RS1157093222 (X:48191363 A>C)
Disease associations
OMIM: gene MIM:300327 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
8 total (human), top 8 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Temozolomide | increases expression | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Cadmium | decreases expression, increases abundance | 1 |
| Diethylhexyl Phthalate | increases expression | 1 |
| Endosulfan | increases expression | 1 |
| Tetrachlorodibenzodioxin | decreases expression | 1 |
| Valproic Acid | decreases expression | 1 |
| Cadmium Chloride | decreases expression, increases abundance | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.